Early data suggest Sanofi, Regeneron drug may halve heart risk By: Reuters: Company News August 31, 2014 at 03:00 AM EDT * Good news for new PCSK9 drug class but needs confirmation Read More >> Related Stocks: Amgen Banco Santander ADR Biomarin Pharmaceuticals Pfizer Regeneron Pharmaceuticals